StockData
PROCEPT BioRobotics Corp logo

PROCEPT BioRobotics Corp (PRCT) stock

PRCTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3049% below fair value
$25.18+1.40 (+5.89%)

Close on Nov 18, 2026Market cap $1.44BP/E –Yield –

PROCEPT BioRobotics free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

PROCEPT BioRobotics's free cash flow for the twelve months ending Jun 30, 2026 was -$84.93M. For fiscal 2025 it was -$58.34M. The highest annual figure on record is -$48.58M in fiscal 2020.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$58.34M–
FY2024Dec 31, 2024-$103.62M–
FY2023Dec 31, 2023-$133.21M–
FY2022Dec 31, 2022-$83.04M–
FY2021Dec 31, 2021-$57.93M–
FY2020Dec 31, 2020-$48.58M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$22.20M–
Q1 FY2026Mar 31, 2026-$41.04M–
Q4 FY2025Dec 31, 2025-$12.18M–
Q3 FY2025Sep 30, 2025-$9.50M–
Q2 FY2025Jun 30, 2025-$17.85M–
Q1 FY2025Mar 31, 2025-$18.82M–
Q4 FY2024Dec 31, 2024-$33.57M–
Q3 FY2024Sep 30, 2024-$19.05M–
Q2 FY2024Jun 30, 2024-$16.78M–
Q1 FY2024Mar 31, 2024-$34.23M–
Q4 FY2023Dec 31, 2023-$33.51M–
Q3 FY2023Sep 30, 2023-$24.72M–
Q2 FY2023Jun 30, 2023-$33.71M–
Q1 FY2023Mar 31, 2023-$41.27M–
Q4 FY2022Dec 31, 2022-$26.04M–
Q3 FY2022Sep 30, 2022-$21.37M–
Q2 FY2022Jun 30, 2022-$17.34M–
Q1 FY2022Mar 31, 2022-$18.29M–
Q4 FY2021Dec 31, 2021-$16.81M–
Q3 FY2021Sep 30, 2021-$12.86M–
Q2 FY2021Jun 30, 2021-$13.02M–
Q1 FY2021Mar 31, 2021-$15.24M–
Q4 FY2020Dec 31, 2020-$13.45M–

More PROCEPT BioRobotics figures

See a number that looks wrong?